2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy

Background: Colorectal cancer (CRC) is one of the deadliest cancers worldwide and long-term survival is not guaranteed in metastatic disease despite current multidisciplinary therapies. A new compound 2,3,5,4′-Tetrahydroxystilbene (TG1), derived from THSG (2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Kuei-Yen, Wei, Po-Li, Lee, Cheng-Chin, Makondi, Precious Takondwa, Chen, Hsin-An, Chang, Yao-Yuan, Liu, Der-Zen, Huang, Chien-Yu, Chang, Yu-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376355/
https://www.ncbi.nlm.nih.gov/pubmed/37509438
http://dx.doi.org/10.3390/biomedicines11071798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376355/
https://www.ncbi.nlm.nih.gov/pubmed/37509438
http://dx.doi.org/10.3390/biomedicines11071798

Ejemplares similares